BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in rare colorectal cancer trial
Disease control CompletedThis study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. The goal was to see how much the tumor shrank and to check for side effects. Only 2 pe…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New study tracks how melanoma patients use a smartphone app during treatment
Knowledge-focused CompletedThis study followed 400 adults with advanced BRAF-mutant melanoma who were taking targeted therapy (BRAF/MEK inhibitors) and using a smartphone app called TavieSkin. The goal was to describe patient characteristics, how they used the app, and how the treatment affected their qual…
Matched conditions: BRAF V600 MUTATION
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC